Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ishimitsu, T.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Alcohol Intake and Cardiac Hypertrophy in Hypertensive Patients

right arrow Toshihiko Ishimitsu, MD

15 April 1997 | Volume 126 Issue 8 | Page 666


TO THE EDITOR:

Excessive alcohol intake is known to promote the development of hypertension. However, some studies have found a J-shaped curve when alcohol consumption is compared with blood pressure [1]. Furthermore, several studies have reported a lower incidence of coronary heart disease in light-to-moderate drinkers than in those who abstain, possibly because of increased levels of high-density lipoprotein cholesterol [2]. Therefore, the overall benefits and risks brought about by alcohol intake should be carefully assessed before hypertensive patients are advised about alcohol intake. The ultimate purpose of antihypertensive therapy is to inhibit target-organ injuries and cardiovascular diseases. This should be considered when the optimal alcohol intake for a hypertensive patient is being evaluated; however, little work has been done to determine the relation between alcohol intake and development of hypertensive organ injuries.

We investigated the influence of alcohol intake on cardiac hypertrophy in 302 untreated hypertensive patients who were selected from 4557 men who entered the health-check program of our institute from 1990 to 1994. Hypertension was defined as blood pressure exceeding 140/90 mm Hg after 15 minutes of supine rest. According to the daily alcohol consumption obtained by a self-administered questionnaire, the patients were classified into four categories: nondrinker (0 to 10 mL of ethanol per day), light drinker (11 to 29 mL/d), moderate drinker (30 to 58 mL/d) and heavy drinker (≥ 59 mL/d). A 12-lead resting electrocardiogram was recorded, and signs of left ventricular hypertrophy were evaluated using the revised Minnesota code [3]. Although blood pressure levels were similar among the groups, electrocardiographic findings of left ventricular hypertrophy were increased in moderate and heavy drinkers but not in light drinkers (Table 1) (P < 0.01). Serum {gamma}-glutamyl transpeptidase and triglyceride levels were increased in moderate and heavy drinkers, which suggests that alcohol intake was reported reliably. Serum levels of high-density lipoprotein cholesterol were increased even among light drinkers compared with nondrinkers, but no change was seen in total cholesterol levels.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Hypertensive Patients Grouped by Alcohol Consumption*

 

These findings suggest that habitual consumption of ethanol in excess of 29 mL/d facilitates the development of left ventricular hypertrophy in hypertensive patients, even when blood pressure is not elevated. Hypertensive patients who are light drinkers seem to receive the greatest benefit in terms of the prevention of organ injuries and reduction of risks for cardiovascular disease. Thus, our investigation shows that excessive alcohol intake is associated with an increased occurrence of left ventricular hypertrophy that is independent of blood pressure in hypertensive patients. In addition to alcohol-induced myocardial damage, the mechanism of this increased cardiac hypertrophy in moderate drinkers may involve the effects of long-term alcohol consumption on whole-day blood pressure variation and humoral factors such as angiotensin II and catecholamines, which are known to stimulate cardiomyocyte hypertrophy [4, 5].


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

National Cardiovascular Center, Suita, Osaka 565, Japan


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Criqui MN, Wallace RB, Mishkel M, Barrett-Conner E, Heiss G. Alcohol consumption and blood pressure: the Lipid Research Clinics Prevalence Study. Hypertension. 1981; 3:557-65.

2. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med. 1992; 117:646-54.

3. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies: a classification system. Circulation. 1960; 21:1160-75.

4. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an {alpha} 1-adrenergic response. J Clin Invest. 1983; 72:732-8.

5. Dahlof B, Herlitz H, Aurell M, Hansson L. Reversal of cardiovascular structural changes when treating essential hypertension: the importance of the renin-angiotensin-aldosterone system. Am J Hypertens. 1992; 5:900-11.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
M. Schröter, H.-H. Feucht, P. Schäfer, B. Zöllner, and R. Laufs
Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay
J. Clin. Microbiol., August 1, 1999; 37(8): 2576 - 2580.
[Abstract] [Full Text]


box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Ishimitsu, T.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online